Immunohistochemical studies have revealed a strikingly increased local immunoglobulin G (IgG) production,2 predominantly of the complement binding IgGI subclass although Crohn's disease mucosa contains a higher percentage of IgG2 containing immunocytes than ulcerative colitis. 3 The same result has been obtained by cultivation of mononuclear cells from the lesion. ' Patients with Crohn's disease are reported to have impaired C3b inactivation' and increased complement C3 catabolism`6 with raised serum concentrations of complement C3 activation split products.9 "' These findings suggest that complement activation takes place in the affected intestinal mucosa.
To address this issue we examined directly ethanol fixed as well as extensively pre-washed mucosal specimens from patients with Crohn's disease in the ileum and/or colon. Monoclonal antibody (mAb) to activation neoepitopes in the early (C3b) and late (terminal complement complex complement activation pathway were used.
The results showed deposition of both C3b and terminal complement complex in these deposits, however, in contrast with our previous observations in ulcerative colitis."
Methods

TISSUE SPECIMENS
Mucosal tissue samples were immediately excised from surgically resected colon (n=56) or terminal ileum (n=26) from 21 patients with Crohn's disease (median age 29 yr, range 14-64). Three patients had only ileal involvement, one only colonic, whereas 17 had both segments affected (ileal biopsy available only in 11). The patients had been observed clinically for two to 13 years (median five years). Ulcerative colitis specimens (five) with epithelial complement and IgGI deposits were selected from 23 previously reported patients." Control material was obtained from histologically normal colonic mucosa of 26 patients as described elsewhere" and normal ileal mucosa (six).
All tissue specimens were placed in ice cold isotonic saline and brought to the laboratory within one hour for preparation in two alternative ways. Trimmed tissue blocks (about 2 x4x 5 mm) were either fixed directly in cold 96% ethanol for 18 Primary incubation with murine control ascites or normal rabbit serum, at dilutions similar to those used for monoclonal antibodies and rabbit antisera, did not produce immunofluorescence.
The relation between mucus associated and/or epithelium related terminal complement complex/C3b deposits and inflammation was based on Kendall's correlation analysis.
Results
ILEAL COMPLEMENT DEPOSITS
Staining for C3b-neo (monoclonal antibody bH6) was observed within the ileal surface mucus layer in directly fixed specimens from eight of 14 patients. Additional but weaker and scattered staining for terminal complement complex was observed in five of these patients. A distinct epithelium related apical staining for C3b was observed in seven patients, and four of them showed terminal complement complex at the same location (Table) C3b often dominated throughout the mucus layer whereas terminal complement complex appeared to be located closer to the epithelial surface and was then scored as epithelium related (Fig 1) . Only the staining intensity of epithelium related and mucus associated terminal complement complex was significantly correlated with the topical degree of inflammation (Fig 2) , although wide scatter was observed. Fine granular staining for terminal complement complex and S-protein was present in the basement membrane zone of five patients, whereas C3b was seen in only one. No epithelial deposition of Clq, C4c or any of the four IgG subclasses was detected in the prewashed specimens.
An approximately 100 ,um broad zone of the mucosal wall surrounding ileal ulcers stained diffusely for terminal complement complex, and numerous terminal complement complex positive globular elements were observed in the luminal content (not shown).
COLONIC COMPLEMENTS DEPOSITS
Crohn's disease Often granular and parallel positivity for C3b (Fig 3) and terminal complement complex was observed at the luminal face of the epithelium in 10 of 18 patients with Crohn's disease of the colon (Table) terminal complement complex positivity was more diffuse (not shown). Similar C3b positive elements were observed attached to and/or located within the epithelium in nine patients. Aggregates of C3b positive globular elements were observed in the lamina propria in directly ethanol fixed specimens from six patients (Fig 4) . These aggregates were apparently located within lymphatic vessels as visualised also with avidin biotin complex peroxidase (Fig 4C) (though weaker than for C3b/C3c). Such deposits were observed in all three samples (Fig 6) . C3b/ terminal complement complex positive deposits in the absence of both IgGI and C4c/C lq were also observed. The other two samples contained either epithelial C3b and terminal complement complex deposits in the absence ofIgGi and Clq/ C4c, or only IgG 1 in the absence of complement components.
C3b positive globular elements were often observed in the lumen and were attached to the surface epithelium in one of the ulcerative colitis samples.
VASCULAR COMPLEMENT Submucosal blood vessels in both ileum and The two complement activation pathways are not strictly separate because antibodies and immune complexes may also activate the alternative pathway,22 and agents such as cardiolipin,2' C-reactive protein2425 and bacterial (Escherichia coli) surface antigens26 may initiate the classical pathway. In addition, C3b produced by classical activation may complex with factor B to generate the alternative pathway C3 convertase (C3bBb), resulting in increased C3 activation (alternative pathway amplification). It is therefore difficult to determine the main activation pathway on the basis of immunohistochemical staining for complement components in immune deposits. Nevertheless, codeposition of IgGI in ulcerative colitis but not in Crohn's disease, strongly suggests that autoantibodies to the colonic epithelium are involved in the epithelial complement deposition only in the former disease. Also, patients with Crohn's disease have been found to have higher serum levels of the alternative pathway activation product Bb than patients with ulcerative colitis. 8 The subepithelial deposition of C3d, terminal complement complex and S-protein (presumably representing the soluble form of terminal complement complex, SC5b-9) observed in affected ileum and colon might have represented fluid face complement activation secondary to epithelial destruction. Alternatively, soluble immune complexes generated in the basement membrane zone could have induced subepithelial compliment activation and induced epithelial damage. These deposits, however, were mainly seen beneath intact epithelium in Crohn's disease, contrasting with ulcerative colitis where such deposits primarily were observed beneath or close to damaged epithelium.
Ahrenstedt et a127 recently reported that patients with Crohn's disease of the ileum have increased concentrations of C3 in jejunal lavage fluid. It was suggested that this finding reflected activated C3 because most was of a molecular size similar to the complement split product C3c.
This does not seem to be a general small intestinal phenomenon, however, because C3b/C3c positivity (mAb bH6) was observed only in mucus of affected ileum.
The epithelial complement deposition in Crohn's colitis tended to be more Many patients whose complaints refer to the gastrointestinal tract have disorders of function. It is, therefore, surprising that the techniques of nuclear medicine are underused in this specialty. The main role of radionuclide techniques is in the non-invasive demonstration of pathophysiological disorders. The motility and synchronisation of oesophageal contraction is given by a few swallows of 'Tc labelled fruit juice. Gastrooesophageal reflux and gastric emptying, small bowel transit and colonic motility in constipation, irritable bowel syndrome, and diarrhoea are able to be assessed non-invasively. There is the demonstration of the site of gastrointestinal bleeding before angiography, and the use of radioactive B,2 and SeHCAT ("Se homotaurocholate) and 14C breath tests in defining the nature of malabsorption.
The evaluation of inflammatory bowel disease and the demonstration of abscess with radiolabelled white cells are discussed. Liver blood flow, biliary kinetics, gallbladder function, and hyposplenia are considered. The distinction between recurrence of colorectal cancer and postsurgical fibrosis is made with radiolabelled monoclonal antibodies. All these subjects and more are covered clearly, concisely, and with a clinical emphasis in this genuine pocket book. It is essential reading for gastroenterologists both in training and retraining. It is strongly recommended. 
